Ya Ding Selected Research

Ya Ding Research Topics

Disease

31	Neoplasms (Cancer) 05/2021 - 01/2005
13	Melanoma (Melanoma, Malignant) 10/2022 - 12/2012
6	Liver Neoplasms (Liver Cancer) 11/2019 - 12/2013
4	Colonic Neoplasms (Colon Cancer) 12/2018 - 08/2009
3	Lung Neoplasms (Lung Cancer) 08/2016 - 10/2009
3	Carcinoma (Carcinomatosis) 06/2013 - 01/2005
2	Renal Cell Carcinoma (Grawitz Tumor) 05/2021 - 01/2021
2	Malaria 01/2020 - 10/2011
2	Neoplasm Metastasis (Metastasis) 10/2019 - 04/2014
2	Stomach Neoplasms (Stomach Cancer) 01/2019 - 01/2015
2	Colorectal Neoplasms (Colorectal Cancer) 12/2018 - 10/2009
2	Infections 01/2016 - 03/2015
1	Clear Cell Sarcoma 12/2021
1	Hepatocellular Carcinoma (Hepatoma) 03/2021
1	Inflammation (Inflammations) 01/2021
1	Hypothyroidism 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Cognitive Dysfunction 01/2020
1	Hypoxia (Hypoxemia) 10/2019
1	Flatulence 12/2018
1	Necrosis 11/2018
1	Hand-Foot Syndrome 01/2018
1	Exanthema (Rash) 01/2018
1	Mucositis 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Dermatofibrosarcoma 01/2018
1	Sarcoma (Soft Tissue Sarcoma) 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Nausea 01/2018
1	Diarrhea 01/2018
1	Fever (Fevers) 09/2017
1	Fatigue 09/2017
1	Adenoviridae Infections (Adenovirus Infections) 08/2016

Drug/Important Bio-Agent (IBA)

7	Pharmaceutical PreparationsIBA 12/2021 - 10/2011
6	GoldIBA 01/2021 - 12/2013
5	Immune Checkpoint InhibitorsIBA 01/2021 - 09/2015
4	Paclitaxel (Taxol)FDA LinkGeneric 09/2017 - 12/2012
3	pembrolizumabIBA 01/2021 - 01/2016
3	PolymersIBA 11/2019 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2015
2	pazopanib FDA Link 05/2021 - 01/2018
2	Axitinib (AG 013736)IBA 05/2021 - 01/2021
2	Transferrin (beta 2 Transferrin)IBA 03/2021 - 12/2018
2	Transaminases (Aminotransferases)IBA 01/2021 - 09/2017
2	Biological ProductsIBA 01/2021 - 01/2020
2	IonsIBA 10/2019 - 11/2018
2	Sunitinib (Sutent)FDA Link 01/2018 - 01/2018
2	IpilimumabIBA 09/2017 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 02/2017 - 06/2013
2	Antineoplastic Agents (Antineoplastics)IBA 02/2017 - 01/2016
2	Liposomes (Liposome)IBA 01/2016 - 12/2014
1	Protein CoronaIBA 03/2021
1	IntegrinsIBA 03/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2021
1	InterferonsIBA 01/2021
1	trametinibIBA 01/2021
1	dabrafenibIBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	BilirubinIBA 01/2021
1	Protein AggregatesIBA 01/2020
1	artenimol (dihydroartemisinin)IBA 01/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	LactonesIBA 01/2020
1	SesquiterpenesIBA 01/2020
1	Hydroxyl RadicalIBA 10/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2019
1	hyaluronan-mediated motility receptorIBA 01/2019
1	Serum AlbuminIBA 12/2018
1	Prealbumin (Transthyretin)IBA 12/2018
1	C-Reactive ProteinIBA 11/2018
1	Mitochondrial DNA (mtDNA)IBA 11/2018
1	Adenosine Triphosphate (ATP)IBA 11/2018
1	ProcalcitoninIBA 11/2018
1	CalciumIBA 11/2018
1	puquitinibIBA 10/2018
1	Sorafenib (BAY 43-9006)FDA Link 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 01/2018
1	GalactosidasesIBA 01/2018
1	Cytotoxins (Cytolysins)IBA 01/2018
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2018
1	pyridineIBA 01/2018
1	Complement System Proteins (Complement)IBA 10/2017
1	Asialoglycoprotein ReceptorIBA 09/2017
1	Galactose (Galactopyranose)FDA LinkGeneric 09/2017
1	NanocapsulesIBA 02/2017
1	ChitosanIBA 02/2017
1	Cys-ZHER2-342 affibodyIBA 01/2017
1	trichostatin A (A 300)IBA 08/2016

Therapy/Procedure

19	Therapeutics 03/2021 - 10/2006
4	Immunotherapy 10/2022 - 01/2005
4	Drug Therapy (Chemotherapy) 01/2019 - 10/2011
1	Neoadjuvant Therapy 05/2021
1	Nephrectomy 05/2021
1	Aftercare (After-Treatment) 01/2020
1	Length of Stay 12/2018
1	Enteral Nutrition (Feeding, Tube) 12/2018
1	Oral Administration 10/2018
1	Photothermal Therapy 01/2017
1	Precision Medicine 01/2017